There will be a massive growth in revenue for the Anticoagulant Reversal Drugs Industry through 2027

Anticoagulant Reversal Drugs are required to reverse the effect of anticoagulation in certain situations such as unplanned surgery, overdose of anticoagulant therapy, and uncontrolled bleeding. In medical conditions such as venous thromboembolism, atrial fibrillation (AF), mechanical valve replacement, and other coagulation disorders such as antiphospholipid antibody syndrome, Factor V Leiden, anticoagulant reversal drugs are used.

Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPRE00004954/

Various players operating in the anticoagulant reversal drugs market are developing and launching new products to expand their geographic reach and capacity to cater a large number of customers. In April 2018, Boehringer Ingelheim, a leading pharmaceutical company, received the US Food and Drug Administration (FDA) full approval for Praxbind (idarucizumab), the specific reversal agent for Pradaxa (dabigatran etexilate mesylate). Additionally, in January 2019, AMAG Pharmaceuticals acquired Perosphere Pharmaceuticals, a private biopharmaceutical company. AMAG Pharmaceuticals, through this acquisition expanded its anticoagulant reversal ciraparantag to its portfolio. Similarly, in May 2018, Portola Pharmaceuticals received FDA approval for the rapid reversal of anticoagulation due to major bleeding. Such developments and approvals of new products are likely to favor the market growth.

Geographically, the anticoagulant reversal drugs market is segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America held the largest market share in 2019. In North America, the US is the largest market for anticoagulant reversal drugs. The growth of the market in the region is attributed to the presence of key market players and their product development efforts. Additionally, the escalating prevalence of atrial fibrillation further contributes to the growth of the anticoagulant reversal drugs market in North America.

Contact Us:

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

 

Comments

Post a Comment

Popular posts from this blog

Ophthalmoscopes Industry requirement with CAGR of 4.6% during 2021–2027

The global leaders are expanding their activities across the world and are developing various innovative techniques to diagnose the eye conditions. For instance, Carl Zeiss MediaTek AG has launched total keratometry for the IOLMaster 700 that offers opportunities to cataract surgeons for the replacement of assumptions about the posterior corneal surface with precise measurements, which will enhance their results. Additionally, the company has also announced receiving approval from FDA for its Advanced Nerve and Glaucoma Imaging (A N G I) Network. The major goal of the company is to enhance the global collaborations so as to elevate the latest research in Glaucoma and optic nerve diseases. Thus, the considering these developments the for the ophthalmology industry the players operating for the ophthalmoscopes are likely to improve their performance and provide enormous benefits to their customers and end users. Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPRE00002861/...
Read more

In the years ahead, the Diagnostic Imaging Industry will generate a massive amount of revenue

Diagnostic medical imaging is a common technique to help visualize physical diagnosis in the clinical community. For diagnostic purposes, these systems are employed to image the body to obtain a correct diagnosis and determine future care. Diagnostic Imaging is the technique or process of creating visual illustrations of the inner body for clinical examination and medical interpolation, along with the visual representation of the function of certain organs or tissues. It has a broad range of applications in a variety of oncological, orthopaedic, gastroenterology, and gynaecological fields. Get Sample Copy@ https://www.theinsightpartners.com/sample/TIPHE100001107/ According to our new research study on "Diagnostic Imaging Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Modality, Application, and End User," the market is expected to grow from US$ 36,344.54 million in 2021 to US$ 53,410.59 million by 2028; it is estimated to grow at a CAGR of 5.8% from 2...
Read more

Air Management System Market 2022 Industry Outlook, Comprehensive Insights, Growth and Forecast 2028

The overall size of the air management system market has been derived using both primary and secondary sources. To begin the research process, exhaustive secondary research has been conducted using internal and external sources to obtain qualitative and quantitative information related to the market. The process also serves the purpose of obtaining an overview and forecast for the air management system market concerning all the segments in the region. Also, multiple primary interviews have been conducted with industry participants and commentators to validate the data and gain more analytical insights into the topic. The participants of this process include industry experts such as VPs, business development managers, market intelligence managers, and national sales managers—along with external consultants such as valuation experts, research analysts, and key opinion leaders—specializing in the air management system market. Get Sample Copy@ https://www.theinsightpartners.com/sample/T...
Read more